# High Flow Nasal Oxygen Cannula in Transcatheter Aortic Valve Replacement: Complications and Biomarkers

Study · id `cardio:ct-nct05958537` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT05958537](<https://clinicaltrials.gov/study/NCT05958537>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT05958537

Browse, organ or system: Heart  
Browse, condition area: Valve and congenital heart disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 132 participants.

## Technical summary

Registry record NCT05958537. Randomized; no masking; primary purpose treatment. Start 2023-11-01 (actual); primary completion 2024-07-01 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 132 participants (enrolled count; ClinicalTrials.gov record NCT05958537, source copy `cardio:ctgov-nct05958537-2024-12-19`, retrieved 2026-10-26)
- Started: 2023-11-01 (actual) (ClinicalTrials.gov record NCT05958537, source copy `cardio:ctgov-nct05958537-2024-12-19`, retrieved 2026-10-26)
- Primary completion: 2024-07-01 (actual) (ClinicalTrials.gov record NCT05958537, source copy `cardio:ctgov-nct05958537-2024-12-19`, retrieved 2026-10-26)
- Completion: 2024-07-01 (actual) (ClinicalTrials.gov record NCT05958537, source copy `cardio:ctgov-nct05958537-2024-12-19`, retrieved 2026-10-26)
- Countries: Spain (ClinicalTrials.gov record NCT05958537, source copy `cardio:ctgov-nct05958537-2024-12-19`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct05958537-2024-12-19`, retrieved 2026-10-26)

## The registry's words

- Brief title: High Flow Nasal Oxygen Cannula in Transcatheter Aortic Valve Replacement: Complications and Biomarkers
- Acronym: HIGH-OXY-TAVR
- Condition: Aortic Stenosis
- Condition: Sedation Complication
- Intervention (Device): High flow nasal oxygen
- Lead sponsor: Hospital Clinic of Barcelona
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Aortic stenosis (`cardio:aortic-stenosis`)
- Registry condition terms include this condition: Heart valve disease (`cardio:heart-valve-disease`)
- Registry lists this organization as the lead sponsor: Hospital Clinic of Barcelona (`cardio:org-hospital-clinic-of-barcelona`)

## Provenance

Content hash: 4e48e1f2682729f4e85cb0f8b5434db1dad242955f92f98097a6423207006751
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
